{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:11:29Z","timestamp":1784121089940,"version":"3.55.0"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006190","name":"Gdansk University of Technology","doi-asserted-by":"crossref","award":["DS\/034520"],"award-info":[{"award-number":["DS\/034520"]}],"id":[{"id":"10.13039\/501100006190","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006190","name":"Gdansk University of Technology","doi-asserted-by":"crossref","award":["DS\/034520"],"award-info":[{"award-number":["DS\/034520"]}],"id":[{"id":"10.13039\/501100006190","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical University of Gdansk","award":["ST-54"],"award-info":[{"award-number":["ST-54"]}]},{"name":"Medical University of Gdansk","award":["ST-54"],"award-info":[{"award-number":["ST-54"]}]},{"name":"Foster Foundation, USA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Short peptides conjugated to drugs are found to effectively improve wellbeing and recovery of cancer patients. However, to combat poor stability and bioavailability, their polar groups can be protected to form mimetics. Therefore, here we present synthesis, short biological screening and detailed computational analysis of 18\n                    <jats:italic>N<\/jats:italic>\n                    -terminal \u03b2-alanine and L-histidine dipeptidomimetics, to estimate their preliminary relevance as cancer therapeutics intermediates for conjugation. While extended biological experiments are deeply relevant to define drug functionality, they also require extensive financial resources. Herein, we employed computational methods to better estimate possible activities of the compounds, and create a perspective between in silico and in vitro to hypothesize on the acquired results. Most efficient representatives of each group were \u03b2-Ala-Ala (BAA) and His(Bn)-Val (HV) dipeptidomimetics, which seem to show signs of selectivity. Our research provides detailed theoretical data for scientists searching for their new conjugative agents to study. We hope to encourage other experts to incorporate computational methods into their research, to increase clarity and available data for further research.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-50964-7","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:54:29Z","timestamp":1778918069000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Potential medical applicability of N-\u03b2-Ala and N-His dipeptidomimetics against breast cancer: short in vitro and in silico screening"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5894-9508","authenticated-orcid":false,"given":"Klaudia","family":"Chmielewska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0891-1760","authenticated-orcid":false,"given":"Justyna","family":"Budka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Koz\u0142owska-Tylingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1676-2723","authenticated-orcid":false,"given":"Iwona","family":"Inkielewicz-Stepniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2447-8095","authenticated-orcid":false,"given":"Krystyna","family":"Dzierzbicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"issue":"1","key":"50964_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40169-018-0185-6","volume":"7","author":"H Maeda","year":"2018","unstructured":"Maeda, H. & Khatami, M. Analyses of repeated failures in cancer therapy for solid tumors: Poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs. Clin. Transl. Med. 7(1), 1\u201320 (2018).","journal-title":"Clin. Transl. Med."},{"key":"50964_CR2","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1021\/acs.chemrev.0c00383","volume":"121","author":"RA Ward","year":"2021","unstructured":"Ward, R. A. et al. Challenges and opportunities in cancer drug resistance. Chem. Rev. 121, 3297\u20133351 (2021).","journal-title":"Chem. Rev."},{"key":"50964_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jprot.2013.10.002","volume":"94","author":"J Budczies","year":"2013","unstructured":"Budczies, J. et al. Comparative metabolomics of estrogen receptor positive and estrogen receptor negative breast cancer: Alterations in glutamine and beta-alanine metabolism. J. Proteomics 94, 279\u2013288 (2013).","journal-title":"J. Proteomics"},{"issue":"1","key":"50964_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-024-06435-w","volume":"15","author":"J Chen","year":"2024","unstructured":"Chen, J., Cui, L., Lu, S. & Xu, S. Amino acid metabolism in tumor biology and therapy. Cell Death Dis. 15(1), 1\u201318 (2024).","journal-title":"Cell Death Dis."},{"key":"50964_CR5","first-page":"95","volume":"10","author":"C-Y Wang","year":"2020","unstructured":"Wang, C.-Y. et al. Gene signatures and potential therapeutic targets of amino acid metabolism in estrogen receptor-positive breast cancer. Am. J. Cancer Res. 10, 95\u2013113 (2020).","journal-title":"Am. J. Cancer Res."},{"key":"50964_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-023-11514-w","volume":"23","author":"Y Wang","year":"2023","unstructured":"Wang, Y., Jia, Z., Wang, Q. & Zhu, Z. Amino acids and risk of colon adenocarcinoma: A Mendelian randomization study. BMC Cancer 23, 1\u201310 (2023).","journal-title":"BMC Cancer"},{"key":"50964_CR7","doi-asserted-by":"publisher","first-page":"101862","DOI":"10.1016\/j.mcp.2022.101862","volume":"66","author":"E Baranovicova","year":"2022","unstructured":"Baranovicova, E. et al. Circulating metabolites in the early stage of breast cancer were not related to cancer stage or subtypes but associated with ki67 level. Promising statistical discrimination from controls. Mol. Cell. Probes. 66, 101862 (2022).","journal-title":"Mol. Cell. Probes."},{"key":"50964_CR8","doi-asserted-by":"publisher","first-page":"15688","DOI":"10.1038\/s41598-018-33911-z","volume":"8","author":"J Li\u00f1ares Blanco","year":"2018","unstructured":"Li\u00f1ares Blanco, J., Porto-Pazos, A. B., Pazos, A. & Fernandez-Lozano, C. Prediction of high anti-angiogenic activity peptides in silico using a generalized linear model and feature selection OPEN. Sci. Rep. 8, 15688 (2018).","journal-title":"Sci. Rep."},{"key":"50964_CR9","doi-asserted-by":"publisher","first-page":"200004","DOI":"10.1098\/rsob.200004","volume":"10","author":"M Xie","year":"2020","unstructured":"Xie, M., Liu, D. & Yang, Y. Anti-cancer peptides: Classification, mechanism of action, reconstruction and modification. Open Biol. 10, 200004 (2020).","journal-title":"Open Biol."},{"key":"50964_CR10","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1021\/jm201480u","volume":"55","author":"M Negom Kouodom","year":"2012","unstructured":"Negom Kouodom, M. et al. Toward the selective delivery of chemotherapeutics into tumor cells by targeting peptide transporters: Tailored gold-based anticancer peptidomimetics. J. Med. Chem. 55, 2212\u20132226 (2012).","journal-title":"J. Med. Chem."},{"key":"50964_CR11","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1021\/acschembio.1c00626","volume":"16","author":"A Panjla","year":"2021","unstructured":"Panjla, A., Kaul, G., Chopra, S., Titz, A. & Verma, S. Short peptides and their mimetics as potent antibacterial agents and antibiotic adjuvants. ACS Chem. Biol. 16, 2731\u20132745 (2021).","journal-title":"ACS Chem. Biol."},{"key":"50964_CR12","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/cells10030597","volume":"10","author":"A Wolska","year":"2021","unstructured":"Wolska, A., Reimund, M., Sviridov, D. O., Amar, M. J. & Remaley, A. T. Apolipoprotein mimetic peptides: Potential new therapies for cardiovascular diseases. Cells 10, 597 (2021).","journal-title":"Cells"},{"key":"50964_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cbi.2017.11.019","volume":"279","author":"S Banerjee","year":"2018","unstructured":"Banerjee, S., Sinha, K., Chowdhury, S. & Sil, P. C. Unfolding the mechanism of cisplatin induced pathophysiology in spleen and its amelioration by carnosine. Chem. Biol. Interact. 279, 159\u2013170 (2018).","journal-title":"Chem. Biol. Interact."},{"key":"50964_CR14","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1021\/acs.chemrestox.0c00010","volume":"33","author":"K Chmielewska","year":"2020","unstructured":"Chmielewska, K., Dzierzbicka, K., Inkielewicz-St\u0119pniak, I. & Przyby\u0142owska, M. Therapeutic potential of carnosine and its derivatives in the treatment of human diseases. Chem. Res. Toxicol. 33, 1561\u20131578 (2020).","journal-title":"Chem. Res. Toxicol."},{"key":"50964_CR15","doi-asserted-by":"publisher","first-page":"119117","DOI":"10.1016\/j.bbamcr.2021.119117","volume":"1868","author":"MD Turner","year":"2021","unstructured":"Turner, M. D., Sale, C., Garner, A. C. & Hipkiss, A. R. Anti-cancer actions of carnosine and the restoration of normal cellular homeostasis. Biochim. Biophys. Acta 1868, 119117 (2021).","journal-title":"Biochim. Biophys. Acta"},{"key":"50964_CR16","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.2174\/0929867326666190711102718","volume":"27","author":"S Menini","year":"2019","unstructured":"Menini, S., Iacobini, C., Fantauzzi, C. B. & Pugliese, G. L-carnosine and its derivatives as new therapeutic agents for the prevention and treatment of vascular complications of diabetes. Curr. Med. Chem. 27, 1744\u20131763 (2019).","journal-title":"Curr. Med. Chem."},{"key":"50964_CR17","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s11094-024-03185-z","volume":"58","author":"TN Fedorova","year":"2024","unstructured":"Fedorova, T. N. et al. New derivative of pyrrole and carnosine: Synthesis, physicochemical properties, and biological acivity. Pharm. Chem. J. 58, 617\u2013624 (2024).","journal-title":"Pharm. Chem. J."},{"key":"50964_CR18","doi-asserted-by":"publisher","first-page":"5083","DOI":"10.3390\/molecules29215083","volume":"29","author":"A Artasensi","year":"2024","unstructured":"Artasensi, A. et al. Exploring secondary amine carnosine derivatives: Design, synthesis, and properties. Molecules 29, 5083 (2024).","journal-title":"Molecules"},{"key":"50964_CR19","first-page":"778","volume":"16","author":"A Bonaccorso","year":"2023","unstructured":"Bonaccorso, A. et al. The therapeutic potential of novel carnosine formulations: Perspectives for drug development. Pharm. 16, 778 (2023).","journal-title":"Pharm."},{"key":"50964_CR20","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1080\/10717544.2022.2089296","volume":"29","author":"R Bajracharya","year":"2022","unstructured":"Bajracharya, R. et al. Functional ligands for improving anticancer drug therapy: Current status and applications to drug delivery systems. Drug Deliv. 29, 1959\u20131970 (2022).","journal-title":"Drug Deliv."},{"key":"50964_CR21","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1039\/D0CS00556H","volume":"50","author":"MB Cooper","year":"2021","unstructured":"Cooper, M. B., Iegre, J., Donovan, D. H. O., Halvarsson, M. \u00d6. & Spring, R. D. Peptides as a platform for targeted therapeutics for cancer: Peptide\u2013drug conjugates (PDCs). Chem. Soc. Rev. 50, 1480\u20131494 (2021).","journal-title":"Chem. Soc. Rev."},{"key":"50964_CR22","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1021\/acs.jmedchem.0c01530","volume":"64","author":"M Alas","year":"2021","unstructured":"Alas, M., Saghaeidehkordi, A. & Kaur, K. Peptide-drug conjugates with different linkers for cancer therapy. J. Med. Chem. 64, 216\u2013232 (2021).","journal-title":"J. Med. Chem."},{"issue":"4","key":"50964_CR23","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/bjc.2015.435","volume":"114","author":"N Diamantis","year":"2016","unstructured":"Diamantis, N. & Banerji, U. Antibody-drug conjugates\u2014an emerging class of cancer treatment. Br. J. Cancer. 114(4), 362\u2013367 (2016).","journal-title":"Br. J. Cancer."},{"issue":"1","key":"50964_CR24","first-page":"1","volume":"12","author":"VR Aldilla","year":"2022","unstructured":"Aldilla, V. R. et al. Hydrogels with intrinsic antibacterial activity prepared from naphthyl anthranilamide (NaA) capped peptide mimics. Sci. Reports 12(1), 1\u201312 (2022).","journal-title":"Sci. Reports"},{"issue":"1","key":"50964_CR25","first-page":"1","volume":"13","author":"HS Ismail","year":"2023","unstructured":"Ismail, H. S., Khalil, A., Taha, R. A., Lasheen, D. S. & Abou El Ella, D. A. Design, molecular modelling and synthesis of novel benzothiazole derivatives as BCL-2 inhibitors. Sci. Reports 13(1), 1\u201318 (2023).","journal-title":"Sci. Reports"},{"issue":"7","key":"50964_CR26","first-page":"1","volume":"7","author":"MC Scala","year":"2017","unstructured":"Scala, M. C. et al. Lactoferrin-derived peptides active towards influenza: Identification of three potent tetrapeptide inhibitors. Sci. Reports 7(7), 1\u201311 (2017).","journal-title":"Sci. Reports"},{"issue":"1","key":"50964_CR27","first-page":"1","volume":"14","author":"PHR Azevedo","year":"2024","unstructured":"Azevedo, P. H. R. et al. Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV-2 Mpro). Sci. Reports 14(1), 1\u201316 (2024).","journal-title":"Sci. Reports"},{"issue":"1","key":"50964_CR28","first-page":"1","volume":"5","author":"K Rajasekhar","year":"2015","unstructured":"Rajasekhar, K., Suresh, S. N., Manjithaya, R. & Govindaraju, T. Rationally designed peptidomimetic modulators of A\u03b2 toxicity in Alzheimer\u2019s disease. Sci. Reports. 5(1), 1\u20139 (2015).","journal-title":"Sci. Reports."},{"issue":"1","key":"50964_CR29","first-page":"1","volume":"7","author":"A Paul","year":"2017","unstructured":"Paul, A., Kalita, S., Kalita, S., Sukumar, P. & Mandal, B. Disaggregation of amylin aggregate by novel conformationally restricted aminobenzoic acid containing \u03b1\/\u03b2 and \u03b1\/\u03b3 hybrid peptidomimetics. Sci. Reports 7(1), 1\u201313 (2017).","journal-title":"Sci. Reports"},{"issue":"6","key":"50964_CR30","first-page":"1","volume":"61","author":"X Wang","year":"2016","unstructured":"Wang, X., Su, H., Wang, W., Chen, C. & Cao, X. Peptidomimetics based on dehydroepiandrosterone scaffold: Synthesis, antiproliferation activity, structure-activity relationship, and mechanisms. Sci. Reports 61(6), 1\u20137 (2016).","journal-title":"Sci. Reports"},{"key":"50964_CR31","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1002\/ejoc.202100240","volume":"2021","author":"L Battistini","year":"2021","unstructured":"Battistini, L., Bugatti, K., Sartori, A., Curti, C. & Zanardi, F. RGD peptide-drug conjugates as effective dual targeting platforms: Recent advances. European J. Org. Chem. 2021, 2506\u20132528 (2021).","journal-title":"European J. Org. Chem."},{"key":"50964_CR32","doi-asserted-by":"publisher","first-page":"e202203476","DOI":"10.1002\/chem.202203476","volume":"29","author":"J Paulus","year":"2023","unstructured":"Paulus, J., Nachtigall, B., Meyer, P. & Sewald, N. RGD peptidomimetic MMAE-conjugate addressing integrin \u03b1V\u03b23-expressing cells with high targeting index. Chem. Eur. J. 29, e202203476 (2023).","journal-title":"Chem. Eur. J."},{"key":"50964_CR33","doi-asserted-by":"publisher","first-page":"112633","DOI":"10.1016\/j.msec.2021.112633","volume":"133","author":"Z Ahmadi","year":"2022","unstructured":"Ahmadi, Z. et al. An injectable self-assembling hydrogel based on RGD peptidomimetic \u03b2-sheets as multifunctional biomaterials. Biomater. Adv. 133, 112633 (2022).","journal-title":"Biomater. Adv."},{"key":"50964_CR34","doi-asserted-by":"publisher","first-page":"7492","DOI":"10.1002\/chem.202001115","volume":"26","author":"A Pina","year":"2020","unstructured":"Pina, A. et al. Multimeric presentation of RGD peptidomimetics enhances integrin binding and tumor cell uptake. Chem. Eur. J. 26, 7492\u20137496 (2020).","journal-title":"Chem. Eur. J."},{"key":"50964_CR35","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.3390\/cancers13112629","volume":"13","author":"NM Grob","year":"2021","unstructured":"Grob, N. M., Schibli, R., B\u00e9h\u00e9, M. & Mindt, T. L. Improved tumor-targeting with peptidomimetic analogs of minigastrin177 lu-pp-f11n. Cancers 13, 2629 (2021).","journal-title":"Cancers"},{"key":"50964_CR36","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.3390\/ijms24043400","volume":"24","author":"J Gomena","year":"2023","unstructured":"Gomena, J. et al. Targeting the gastrin-releasing peptide receptor (GRP-R) in cancer therapy: Development of bombesin-based peptide-drug conjugates. Int. J. Mol. Sci. 24, 3400 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"50964_CR37","doi-asserted-by":"publisher","first-page":"13020","DOI":"10.1021\/acs.chemrev.4c00423","volume":"124","author":"CS Swenson","year":"2024","unstructured":"Swenson, C. S., Mandava, G., Thomas, D. M. & Moellering, R. E. Tackling undruggable targets with designer peptidomimetics and synthetic biologics. Chem. Rev. 124, 13020\u201313093 (2024).","journal-title":"Chem. Rev."},{"key":"50964_CR38","first-page":"39","volume":"21","author":"MHH Tehrani","year":"2018","unstructured":"Tehrani, M. H. H., Bamoniri, A. & Gholibeikian, M. The toxicity study of synthesized inverse carnosine peptide analogues on HepG2 and HT-29 cells. Iran. J. Basic Med. Sci. 21, 39\u201346 (2018).","journal-title":"Iran. J. Basic Med. Sci."},{"key":"50964_CR39","doi-asserted-by":"publisher","first-page":"105100","DOI":"10.1016\/j.bioorg.2021.105100","volume":"114","author":"KA Agha","year":"2021","unstructured":"Agha, K. A. et al. Design, synthesis and pharmacological screening of novel renoprotective methionine-based peptidomimetics: Amelioration of cisplatin-induced nephrotoxicity. Bioorg. Chem. 114, 105100 (2021).","journal-title":"Bioorg. Chem."},{"key":"50964_CR40","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.2174\/092986612802762615","volume":"19","author":"Y Luan","year":"2012","unstructured":"Luan, Y. et al. Design, synthesis, and activity evaluation of a new 5-fluorouracil prodrug containing an Asn-Gly-Arg(NO2)COOCH3 tripeptide. Protein Pept. Lett. 19, 1122\u20131131 (2012).","journal-title":"Protein Pept. Lett."},{"key":"50964_CR41","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ejphar.2014.04.001","volume":"734","author":"S-X Cui","year":"2014","unstructured":"Cui, S.-X., Zhang, H.-L., Xu, W.-F. & Qu, X.-J. 13F-1, a novel 5-fluorouracil prodrug containing an Asn\u2013Gly\u2013Arg (NO2) COOCH3 tripeptide, inhibits human colonic carcinoma growth by targeting aminopeptidase N (APN\/CD13). Eur. J. Pharmacol. 734, 50\u201359 (2014).","journal-title":"Eur. J. Pharmacol."},{"key":"50964_CR42","first-page":"1280","volume":"61","author":"J Sun","year":"2001","unstructured":"Sun, J. et al. CEP1612, a dipeptidyl proteasome inhibitor, induces p21WAF1 and p27KIP1 expression and apoptosis and inhibits the growth of the human lung adenocarcinoma A-549 in nude mice1. Cancer Res. 61, 1280\u20131284 (2001).","journal-title":"Cancer Res."},{"key":"50964_CR43","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.3390\/molecules26154573","volume":"26","author":"GO Moustafa","year":"2021","unstructured":"Moustafa, G. O. et al. Synthesis, characterization, in vitro anticancer potentiality, and antimicrobial activities of novel peptide\u2013glycyrrhetinic-acid-based derivatives. Mol. 26, 4573 (2021).","journal-title":"Mol."},{"key":"50964_CR44","doi-asserted-by":"publisher","first-page":"18908","DOI":"10.1021\/acs.jmedchem.5c00544","volume":"68","author":"J Almaliti","year":"2025","unstructured":"Almaliti, J. et al. Development of macrocyclic peptide-based proteasome inhibitors with enhanced blood-brain barrier penetration for treating brain neoplasms. J. Med. Chem. 68, 18908\u201318929 (2025).","journal-title":"J. Med. Chem."},{"key":"50964_CR45","doi-asserted-by":"publisher","first-page":"462","DOI":"10.2174\/1871520620666200516151456","volume":"21","author":"A Siebert","year":"2020","unstructured":"Siebert, A. et al. Anticancer properties of amino acid and peptide derivatives of mycophenolic acid. Anticancer. Agents Med. Chem. 21, 462\u2013467 (2020).","journal-title":"Anticancer. Agents Med. Chem."},{"key":"50964_CR46","doi-asserted-by":"publisher","first-page":"113653","DOI":"10.1016\/j.bios.2021.113653","volume":"195","author":"MK Nisiewicz","year":"2022","unstructured":"Nisiewicz, M. K. et al. Enzymatic cleavage of specific dipeptide conjugated with ferrocene as a flexible ultra-sensitive and fast voltammetric assay of matrix metalloproteinase-9 considered a prognostic cancer biomarker in plasma samples. Biosens. Bioelectron. 195, 113653 (2022).","journal-title":"Biosens. Bioelectron."},{"key":"50964_CR47","doi-asserted-by":"publisher","first-page":"6197","DOI":"10.1039\/D1SC05738C","volume":"13","author":"H Choi","year":"2022","unstructured":"Choi, H. et al. Intramitochondrial co-assembly between ATP and nucleopeptides induces cancer cell apoptosis. Chem. Sci. 13, 6197\u20136204 (2022).","journal-title":"Chem. Sci."},{"key":"50964_CR48","doi-asserted-by":"publisher","first-page":"8629","DOI":"10.18632\/oncotarget.23667","volume":"9","author":"X Yang","year":"2018","unstructured":"Yang, X. et al. Caspase-3 over-expression is associated with poor overall survival and clinicopathological parameters in breast cancer: A meta-analysis of 3091 cases. Oncotarget 9, 8629\u20138641 (2018).","journal-title":"Oncotarget"},{"key":"50964_CR49","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.3390\/ijms21124464","volume":"21","author":"M Alhassan","year":"2020","unstructured":"Alhassan, M., Kumar, A., Lopez, J., Albericio, F. & de la Torre, B. G. Revisiting NO2 as protecting group of arginine in solid-phase peptide synthesis. Int. J. Mol. Sci. 21, 4464 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"50964_CR50","doi-asserted-by":"publisher","DOI":"10.1021\/ACS.BIOCHEM.4C00657\/ASSET\/IMAGES\/LARGE\/BI4C00657_0005.JPEG","author":"B Maity","year":"2025","unstructured":"Maity, B., Moorthy, H. & Govindaraju, T. Tumor microenvironment pH-sensitive peptidomimetics for targeted anticancer drug delivery. Biochemistry https:\/\/doi.org\/10.1021\/ACS.BIOCHEM.4C00657\/ASSET\/IMAGES\/LARGE\/BI4C00657_0005.JPEG (2025).","journal-title":"Biochemistry"},{"key":"50964_CR51","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1002\/adsc.201700034","volume":"359","author":"RM de Figueiredo","year":"2017","unstructured":"de Figueiredo, R. M., Suppo, J. S., Midrier, C. & Campagne, J. M. Sequential one-pot synthesis of dipeptides through the transient formation of CDI-N-protected \u03b1-aminoesters. Adv. Synth. Catal. 359, 1963\u20131968 (2017).","journal-title":"Adv. Synth. Catal."},{"key":"50964_CR52","doi-asserted-by":"publisher","first-page":"7421","DOI":"10.1021\/jm900622d","volume":"52","author":"RK Sharma","year":"2009","unstructured":"Sharma, R. K., Reddy, R. P., Tegge, W. & Jain, R. Discovery of Trp-His and His-Arg analogues as new structural classes of short antimicrobial peptides. J. Med. Chem. 52, 7421\u20137431 (2009).","journal-title":"J. Med. Chem."},{"key":"50964_CR53","doi-asserted-by":"publisher","first-page":"12148","DOI":"10.1021\/acs.joc.2c01288","volume":"87","author":"E Tosi","year":"2022","unstructured":"Tosi, E., Campagne, J. M. & De Figueiredo, R. M. Amine activation: \u2018Inverse\u2019 dipeptide synthesis and amide function formation through activated amino compounds. J. Org. Chem. 87, 12148\u201312163 (2022).","journal-title":"J. Org. Chem."},{"key":"50964_CR54","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10989-018-9680-2","volume":"25","author":"MH El-Dakdouki","year":"2019","unstructured":"El-Dakdouki, M. H., Daouk, N. & Abdallah, H. Synthesis and characterization of a series of orthogonally protected l-carnosine derivatives. Int. J. Pept. Res. Ther. 25, 379\u2013390 (2019).","journal-title":"Int. J. Pept. Res. Ther."},{"key":"50964_CR55","doi-asserted-by":"publisher","first-page":"10456","DOI":"10.1039\/C5OB01838B","volume":"13","author":"J Ivkovic","year":"2015","unstructured":"Ivkovic, J., Lembacher-Fadum, C. & Breinbauer, R. A rapid and efficient one-pot method for the reduction of N-protected \u03b1-amino acids to chiral \u03b1-amino aldehydes using CDI\/DIBAL-H. Org. Biomol. Chem. 13, 10456\u201310460 (2015).","journal-title":"Org. Biomol. Chem."},{"key":"50964_CR56","doi-asserted-by":"publisher","first-page":"e38685","DOI":"10.1016\/j.heliyon.2024.e38685","volume":"10","author":"SA Melhem","year":"2024","unstructured":"Melhem, S. A. et al. Deciphering angiotensin converting enzyme 2 (ACE2) inhibition dynamics: Carnosine\u2019s modulatory role in breast cancer proliferation\u2014A clinical sciences perspective. Heliyon 10, e38685 (2024).","journal-title":"Heliyon"},{"key":"50964_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-13-14","volume":"13","author":"RA Vaughan","year":"2014","unstructured":"Vaughan, R. A. et al. \u03b2-alanine suppresses malignant breast epithelial cell aggressiveness through alterations in metabolism and cellular acidity in vitro. Mol. Cancer 13, 1\u201310 (2014).","journal-title":"Mol. Cancer"},{"key":"50964_CR58","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s00726-017-2437-y","volume":"49","author":"M Pandurangan","year":"2017","unstructured":"Pandurangan, M. et al. Beta-alanine intercede metabolic recovery for amelioration of human cervical and renal tumors. Amino Acids 49, 1373\u20131380 (2017).","journal-title":"Amino Acids"},{"key":"50964_CR59","doi-asserted-by":"publisher","first-page":"12964","DOI":"10.1021\/acsnano.2c05408","volume":"16","author":"J Zhang","year":"2022","unstructured":"Zhang, J. et al. Arginine supplementation targeting tumor-killing immune cells reconstructs the tumor microenvironment and enhances the antitumor immune response. ACS Nano 16, 12964\u201312978 (2022).","journal-title":"ACS Nano"},{"key":"50964_CR60","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1007\/s10620-008-0215-0","volume":"53","author":"MB Braga-Neto","year":"2008","unstructured":"Braga-Neto, M. B. et al. Alanyl-glutamine and glutamine supplementation improves 5-fluorouracil-induced intestinal epithelium damage in vitro. Dig. Dis. Sci. 53, 2687\u20132696 (2008).","journal-title":"Dig. Dis. Sci."},{"key":"50964_CR61","doi-asserted-by":"publisher","first-page":"33573","DOI":"10.1021\/acsami.9b09065","volume":"11","author":"V Castelletto","year":"2019","unstructured":"Castelletto, V. et al. Self-assembly, tunable hydrogel properties, and selective anti-cancer activity of a carnosine-derived lipidated peptide. ACS Appl. Mater. Interfaces 11, 33573\u201333580 (2019).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"50964_CR62","doi-asserted-by":"publisher","DOI":"10.1080\/10520295.2024.2448490","author":"A Popovi\u0107","year":"2025","unstructured":"Popovi\u0107, A. et al. Karnozin EXTRA\u00ae causes changes in mitochondrial bioenergetics response in MCF-7 and MRC-5 cell lines. Biotech. Histochem. https:\/\/doi.org\/10.1080\/10520295.2024.2448490 (2025).","journal-title":"Biotech. Histochem."},{"key":"50964_CR63","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.biopha.2014.12.003","volume":"69","author":"B Adinolfi","year":"2015","unstructured":"Adinolfi, B., Pellegrino, M. & Baldini, F. Human dermal fibroblasts HDFa can be used as an appropriate healthy control for PMMA nanoparticles-survivin molecular beacon cellular uptake studies. Biomed. Pharmacother. 69, 228\u2013232 (2015).","journal-title":"Biomed. Pharmacother."},{"key":"50964_CR64","doi-asserted-by":"publisher","first-page":"1425504","DOI":"10.3389\/fphar.2024.1425504","volume":"15","author":"O Baothman","year":"2024","unstructured":"Baothman, O. et al. Impact of camel milk lactoferrin peptides against breast cancer cells: In silico and in vitro study. Front. Pharmacol. 15, 1425504 (2024).","journal-title":"Front. Pharmacol."},{"key":"50964_CR65","doi-asserted-by":"publisher","first-page":"103552","DOI":"10.1016\/j.jddst.2022.103552","volume":"74","author":"M Y\u0131ld\u0131r\u0131m","year":"2022","unstructured":"Y\u0131ld\u0131r\u0131m, M. et al. Anti-cancer activity of naringenin loaded smart polymeric nanoparticles in breast cancer. J. Drug Deliv. Sci. Technol. 74, 103552 (2022).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"50964_CR66","doi-asserted-by":"publisher","first-page":"136448","DOI":"10.1016\/j.colsurfa.2025.136448","volume":"712","author":"Y Iqbal","year":"2025","unstructured":"Iqbal, Y., Amin, F., Aziz, M. H., Alhadlaq, H. A. & Alaizeri, Z. A. M. Biomimetic sodium alginate functionalized gold nanoparticles loaded with Trans-resveratrol for in-vitro cancer treatment and intercellular ROS studies against MCF-7 cell lines. Colloids Surf. A Physicochem. Eng. Asp. 712, 136448 (2025).","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"50964_CR67","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.3390\/ijms25115691","volume":"25","author":"A Ferraresi","year":"2024","unstructured":"Ferraresi, A. et al. Ovarian cancer cell-conditioning medium induces cancer-associated fibroblast phenoconversion through glucose-dependent inhibition of autophagy. Int. J. Mol. Sci. 25, 5691 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"50964_CR68","doi-asserted-by":"publisher","first-page":"13880","DOI":"10.1038\/s41598-020-70796-3","volume":"10","author":"S \u015eim\u015fek","year":"2020","unstructured":"\u015eim\u015fek, S. et al. DNA-damage and cell cycle arrest initiated anti-cancer potency of super tiny carbon dots on MCF7 cell line. Sci. Rep. 10, 13880 (2020).","journal-title":"Sci. Rep."},{"key":"50964_CR69","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1684\/ecn.2016.0372","volume":"27","author":"MM Alsheblak","year":"2016","unstructured":"Alsheblak, M. M., Elsherbiny, N. M., El-Karef, A. & El-Shishtawy, M. M. Protective effects of L-carnosine on CCl4 -induced hepatic injury in rats. Eur. Cytokine Netw. 27, 6\u201315 (2016).","journal-title":"Eur. Cytokine Netw."},{"key":"50964_CR70","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13765-021-00641-2","volume":"64","author":"X Liu","year":"2021","unstructured":"Liu, X. et al. Ellagic acid exerts anti-fibrotic effects on hypertrophic scar fibroblasts via inhibition of TGF-\u03b21\/Smad2\/3 pathway. Appl. Biol. Chem. 64, 67 (2021).","journal-title":"Appl. Biol. Chem."},{"key":"50964_CR71","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s00709-025-02037-1","volume":"262","author":"S \u00d6ner","year":"2025","unstructured":"\u00d6ner, S. et al. Morphological, anatomical, and bioactive properties of Hypericum scabrum L.: Effects on diabetes mellitus, Alzheimer\u2019s disease, and HDFa fibroblasts and U87-MG cancer cells. Protoplasma 262, 857\u2013879 (2025).","journal-title":"Protoplasma"},{"key":"50964_CR72","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.3390\/antiox11122462","volume":"11","author":"J Park","year":"2022","unstructured":"Park, J. et al. L-carnosine attenuates bleomycin-induced oxidative stress via NF\u03baB pathway in the pathogenesis of pulmonary fibrosis. Antioxidants 11, 2462 (2022).","journal-title":"Antioxidants"},{"issue":"1","key":"50964_CR73","first-page":"1","volume":"11","author":"Q Li","year":"2020","unstructured":"Li, Q. et al. Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer. Nat. Commun. 11(1), 1\u201318 (2020).","journal-title":"Nat. Commun."},{"key":"50964_CR74","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.critrevonc.2018.01.012","volume":"124","author":"GA Cardama","year":"2018","unstructured":"Cardama, G. A. et al. Relevance of small GTPase Rac1 pathway in drug and radio-resistance mechanisms: Opportunities in cancer therapeutics. Crit. Rev. Oncol. Hematol. 124, 29\u201336 (2018).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"50964_CR75","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.7150\/jca.24824","volume":"9","author":"S Lou","year":"2018","unstructured":"Lou, S. et al. Prognostic and clinicopathological value of Rac1 in cancer survival: Evidence from a meta-analysis. J. Cancer 9, 2571 (2018).","journal-title":"J. Cancer"},{"key":"50964_CR76","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3390\/cancers12030665","volume":"12","author":"L Kotelevets","year":"2020","unstructured":"Kotelevets, L. & Chastre, E. Rac1 signaling: From intestinal homeostasis to colorectal cancer metastasis. Cancers 12, 665 (2020).","journal-title":"Cancers"},{"issue":"Suppl 3","key":"50964_CR77","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000088478","volume":"69","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet, P. VEGF as a key mediator of angiogenesis in cancer. Oncology 69(Suppl 3), 4\u201310 (2005).","journal-title":"Oncology"},{"key":"50964_CR78","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1016\/j.yexcr.2007.05.027","volume":"313","author":"TA Garrett","year":"2007","unstructured":"Garrett, T. A., Van Buul, J. D. & Burridge, K. VEGF-induced Rac1 activation in endothelial cells is regulated by the guanine nucleotide exchange factor Vav2. Exp. Cell Res. 313, 3285\u20133297 (2007).","journal-title":"Exp. Cell Res."},{"key":"50964_CR79","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-0-387-74039-3_9","volume":"608","author":"M Tan","year":"2007","unstructured":"Tan, M. & Yu, D. Molecular mechanisms of ErbB2-mediated breast cancer chemoresistance. Adv. Exp. Med. Biol. 608, 119\u2013129 (2007).","journal-title":"Adv. Exp. Med. Biol."},{"key":"50964_CR80","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nm.2385","volume":"17","author":"Q Huang","year":"2011","unstructured":"Huang, Q. et al. Caspase 3\u2013mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat. Med. 17, 860\u2013866 (2011).","journal-title":"Nat. Med."},{"key":"50964_CR81","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/jmr.2541","volume":"29","author":"M Pandurangan","year":"2016","unstructured":"Pandurangan, M., Enkhtaivan, G. & Kim, D. H. Therapeutic efficacy of natural dipeptide carnosine against human cervical carcinoma cells. J. Mol. Recognit. 29, 426\u2013435 (2016).","journal-title":"J. Mol. Recognit."},{"key":"50964_CR82","doi-asserted-by":"publisher","first-page":"108230","DOI":"10.1016\/j.jnutbio.2019.108230","volume":"74","author":"B Hwang","year":"2019","unstructured":"Hwang, B. et al. Carnosine exerts antitumor activity against bladder cancers in vitro and in vivo via suppression of angiogenesis. J. Nutr. Biochem. 74, 108230 (2019).","journal-title":"J. Nutr. Biochem."},{"key":"50964_CR83","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"50964_CR84","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2174\/0113895575362479241231054240","volume":"25","author":"MAM Noordin","year":"2025","unstructured":"Noordin, M. A. M. et al. In vivo pharmacokinetic and ADMET profiles of synthetic antimicrobial peptides (AMPs). Mini Rev. Med. Chem. 25, 579\u2013590 (2025).","journal-title":"Mini Rev. Med. Chem."},{"key":"50964_CR85","doi-asserted-by":"publisher","first-page":"e09629","DOI":"10.1016\/j.heliyon.2022.e09629","volume":"8","author":"C Dang","year":"2022","unstructured":"Dang, C., Okagu, O., Sun, X. & Udenigwe, C. C. Bioinformatics analysis of adhesin-binding potential and ADME\/Tox profile of anti-Helicobacter pylori peptides derived from wheat germ proteins. Heliyon 8, e09629 (2022).","journal-title":"Heliyon"},{"key":"50964_CR86","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1080\/00498254.2022.2119180","volume":"52","author":"S Esposito","year":"2022","unstructured":"Esposito, S., Orsatti, L. & Pucci, V. Subcutaneous catabolism of peptide therapeutics: Bioanalytical approaches and ADME considerations. Xenobiotica 52, 828\u2013839 (2022).","journal-title":"Xenobiotica"},{"key":"50964_CR87","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/19420862.2015.1115937","volume":"8","author":"J Tibbitts","year":"2016","unstructured":"Tibbitts, J., Canter, D., Graff, R., Smith, A. & Khawli, L. A. Key factors influencing ADME properties of therapeutic proteins: A need for ADME characterization in drug discovery and development. MAbs 8, 229\u2013245 (2016).","journal-title":"MAbs"},{"key":"50964_CR88","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.xphs.2020.09.057","volume":"110","author":"JH Hochman","year":"2021","unstructured":"Hochman, J. H. Adapting ADME and pharmacokinetic analysis to the next generation of therapeutic modalities. J. Pharm. Sci. 110, 35\u201341 (2021).","journal-title":"J. Pharm. Sci."},{"key":"50964_CR89","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.2174\/092986711795029609","volume":"18","author":"DJ Adams","year":"2011","unstructured":"Adams, D. J. & Morgan, L. R. Tumor physiology and charge dynamics of anticancer drugs: Implications for camptothecin-based drug development. Curr. Med. Chem. 18, 1367 (2011).","journal-title":"Curr. Med. Chem."},{"key":"50964_CR90","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.cellsig.2009.01.012","volume":"21","author":"EA Dunlop","year":"2009","unstructured":"Dunlop, E. A. & Tee, A. R. Mammalian target of rapamycin complex 1: Signalling inputs, substrates and feedback mechanisms. Cell. Signal. 21, 827\u2013835 (2009).","journal-title":"Cell. Signal."},{"key":"50964_CR91","doi-asserted-by":"publisher","first-page":"114192","DOI":"10.1016\/j.ab.2021.114192","volume":"624","author":"F Kou","year":"2021","unstructured":"Kou, F. et al. Targeted metabolomics in the cell culture media reveals increased uptake of branched amino acids by breast cancer cells. Anal. Biochem. 624, 114192 (2021).","journal-title":"Anal. Biochem."},{"key":"50964_CR92","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.celrep.2019.06.010","volume":"28","author":"M Bacci","year":"2019","unstructured":"Bacci, M. et al. Reprogramming of amino acid transporters to support aspartate and glutamate dependency sustains endocrine resistance in breast cancer. Cell Rep. 28, 104\u2013118 (2019).","journal-title":"Cell Rep."},{"key":"50964_CR93","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.3390\/cancers13143541","volume":"13","author":"CL Chen","year":"2021","unstructured":"Chen, C. L., Hsu, S. C., Ann, D. K., Yen, Y. & Kung, H. J. Arginine signaling and cancer metabolism. Cancers 13, 3541 (2021).","journal-title":"Cancers"},{"key":"50964_CR94","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/jso.24490","volume":"115","author":"VL Albaugh","year":"2017","unstructured":"Albaugh, V. L., Pinzon-Guzman, C. & Barbul, A. Arginine\u2014Dual roles as an onconutrient and immunonutrient. J. Surg. Oncol. 115, 273\u2013280 (2017).","journal-title":"J. Surg. Oncol."},{"issue":"2","key":"50964_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10989-023-10503-8","volume":"29","author":"A Das","year":"2023","unstructured":"Das, A. et al. An updated review on recent advances in the usage of novel therapeutic peptides for breast cancer treatment. Int. J. Pept. Res. Ther. 29(2), 1\u201317 (2023).","journal-title":"Int. J. Pept. Res. Ther."},{"key":"50964_CR96","doi-asserted-by":"publisher","first-page":"74","DOI":"10.2174\/1389203721999201117123616","volume":"22","author":"S Beheshtirouy","year":"2020","unstructured":"Beheshtirouy, S., Mirzaei, F., Eyvazi, S. & Tarhriz, V. Recent advances in therapeutic peptides for breast cancer treatment. Curr. Protein Pept. Sci. 22, 74\u201388 (2020).","journal-title":"Curr. Protein Pept. Sci."},{"key":"50964_CR97","doi-asserted-by":"publisher","first-page":"1052301","DOI":"10.3389\/fphar.2023.1052301","volume":"14","author":"L Li","year":"2023","unstructured":"Li, L. et al. Recent advances in peptide-based therapeutic strategies for breast cancer treatment. Front. Pharmacol. 14, 1052301 (2023).","journal-title":"Front. Pharmacol."},{"key":"50964_CR98","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ejpb.2021.07.010","volume":"167","author":"AB Ilangala","year":"2021","unstructured":"Ilangala, A. B., Lechanteur, A., Fillet, M. & Piel, G. Therapeutic peptides for chemotherapy: Trends and challenges for advanced delivery systems. Eur. J. Pharm. Biopharm. 167, 140\u2013158 (2021).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"50964_CR99","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2220\/biomedres.37.153","volume":"37","author":"Y Yamaguchi","year":"2016","unstructured":"Yamaguchi, Y. et al. Combination of aspartic acid and glutamic acid inhibits tumor cell proliferation. Biomed. Res. 37, 153\u2013159 (2016).","journal-title":"Biomed. Res."},{"key":"50964_CR100","first-page":"5","volume":"4","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y., Wang, C., Zhang, W. & Li, X. Bioactive peptides for anticancer therapies. Biomater. Transl. 4, 5 (2023).","journal-title":"Biomater. Transl."},{"key":"50964_CR101","doi-asserted-by":"publisher","first-page":"115250","DOI":"10.1016\/j.molliq.2020.115250","volume":"328","author":"M Vrane\u0161","year":"2021","unstructured":"Vrane\u0161, M. et al. From amino acids to dipeptide: The changes in thermal stability and hydration properties of \u03b2-alanine, L-histidine and L-carnosine. J. Mol. Liq. 328, 115250 (2021).","journal-title":"J. Mol. Liq."},{"key":"50964_CR102","doi-asserted-by":"publisher","first-page":"2580S","DOI":"10.1093\/jn\/nxaa132","volume":"150","author":"B Petrova","year":"2020","unstructured":"Petrova, B. & Kanarek, N. Potential benefits and pitfalls of histidine supplementation for cancer therapy enhancement. J. Nutr. 150, 2580S-2587S (2020).","journal-title":"J. Nutr."},{"key":"50964_CR103","doi-asserted-by":"publisher","first-page":"100149","DOI":"10.1016\/j.phanu.2019.100149","volume":"8","author":"AA Tantawy","year":"2019","unstructured":"Tantawy, A. A. & Naguib, D. M. Arginine, histidine and tryptophan: A new hope for cancer immunotherapy. PharmaNutrition 8, 100149 (2019).","journal-title":"PharmaNutrition"},{"key":"50964_CR104","first-page":"1084","volume":"3","author":"A Hutschenreuther","year":"2013","unstructured":"Hutschenreuther, A., Birkenmeier, G., Bigl, M., Krohn, K. & Birkemeyer, C. Glycerophosphoglycerol, beta-alanine, and pantothenic acid as metabolic companions of glycolytic activity and cell migration in breast cancer cell lines. Metab. 3, 1084\u20131101 (2013).","journal-title":"Metab."},{"key":"50964_CR105","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/cbdv.200590043","volume":"2","author":"PR Reddy","year":"2005","unstructured":"Reddy, P. R., Mohan, S. K. & Rao, K. S. Ternary Zinc(II)\u2013dipeptide complexes for the hydrolytic cleavage of DNA at physiological pH. Chem. Biodivers. 2, 672\u2013683 (2005).","journal-title":"Chem. Biodivers."},{"key":"50964_CR106","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/antibiotics8020044","volume":"8","author":"R Kuppusamy","year":"2019","unstructured":"Kuppusamy, R., Willcox, M., Black, D. S. C. & Kumar, N. Short cationic peptidomimetic antimicrobials. Antibiot. 8, 44 (2019).","journal-title":"Antibiot."},{"key":"50964_CR107","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1039\/D0CS00102C","volume":"49","author":"E Lenci","year":"2020","unstructured":"Lenci, E. & Trabocchi, A. Peptidomimetic toolbox for drug discovery. Chem. Soc. Rev. 49, 3262\u20133277 (2020).","journal-title":"Chem. Soc. Rev."},{"key":"50964_CR108","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.2174\/1385272825666210610155047","volume":"25","author":"J Han","year":"2021","unstructured":"Han, J., Konno, H., Sato, T., Izawa, K. & Soloshonok, V. A. Peptidomimetics and peptide-based blockbuster drugs. Curr. Org. Chem. 25, 1627\u20131658 (2021).","journal-title":"Curr. Org. Chem."},{"key":"50964_CR109","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.drudis.2016.11.003","volume":"22","author":"N Qvit","year":"2017","unstructured":"Qvit, N., Rubin, S. J. S., Urban, T. J., Mochly-Rosen, D. & Gross, E. R. Peptidomimetic therapeutics: Scientific approaches and opportunities. Drug Discov. Today 22, 454\u2013462 (2017).","journal-title":"Drug Discov. Today"},{"issue":"1","key":"50964_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10020-022-00577-3","volume":"28","author":"MM Gomari","year":"2022","unstructured":"Gomari, M. M. et al. Peptidomimetics in cancer targeting. Mol Med. 28(1), 1\u201317 (2022).","journal-title":"Mol Med."},{"key":"50964_CR111","doi-asserted-by":"publisher","first-page":"7253","DOI":"10.1039\/D0OB01417F","volume":"18","author":"CA Arbour","year":"2020","unstructured":"Arbour, C. A., Mendoza, L. G. & Stockdill, J. L. Recent advances in the synthesis of C-terminally modified peptides. Org. Biomol. Chem. 18, 7253\u20137272 (2020).","journal-title":"Org. Biomol. Chem."},{"key":"50964_CR112","doi-asserted-by":"publisher","first-page":"107341","DOI":"10.1016\/j.phrs.2024.107341","volume":"207","author":"C Li","year":"2024","unstructured":"Li, C. et al. Natural-source payloads used in the conjugated drugs architecture for cancer therapy: Recent advances and future directions. Pharmacol. Res. 207, 107341 (2024).","journal-title":"Pharmacol. Res."},{"key":"50964_CR113","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3892\/ijo.2020.5099","volume":"57","author":"W Chiangjong","year":"2020","unstructured":"Chiangjong, W., Chutipongtanate, S. & Hongeng, S. Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application (review). Int. J. Oncol. 57, 678\u2013696 (2020).","journal-title":"Int. J. Oncol."},{"key":"50964_CR114","first-page":"3147","volume":"35","author":"\u015e Com\u015fa","year":"2015","unstructured":"Com\u015fa, \u015e, C\u00eempean, A. M. & Raica, M. The story of MCF-7 breast cancer cell line: 40 years of experience in research. Anticancer Res. 35, 3147\u20133154 (2015).","journal-title":"Anticancer Res."},{"key":"50964_CR115","unstructured":"Liu, X. et al. PharmMapper server: A web server for potential drug target identification using pharmacophore mapping approach. academic.oup.com."},{"key":"50964_CR116","doi-asserted-by":"publisher","first-page":"W356","DOI":"10.1093\/nar\/gkx374","volume":"45","author":"X Wang","year":"2017","unstructured":"Wang, X. et al. PharmMapper 2017 update: A web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res. 45, W356\u2013W360 (2017).","journal-title":"Nucleic Acids Res."},{"key":"50964_CR117","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1021\/acs.jcim.5b00690","volume":"56","author":"X Wang","year":"2016","unstructured":"Wang, X., Pan, C., Gong, J., Liu, X. & Li, H. Enhancing the enrichment of pharmacophore-based target prediction for the polypharmacological profiles of drugs. J. Chem. Inf. Model. 56, 1175\u20131183 (2016).","journal-title":"J. Chem. Inf. Model."},{"key":"50964_CR118","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1186\/1479-7364-5-6-709","volume":"5","author":"G Stelzer","year":"2011","unstructured":"Stelzer, G. et al. In-silico human genomics with GeneCards. Hum. Genomics 5, 709\u2013717 (2011).","journal-title":"Hum. Genomics"},{"key":"50964_CR119","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/978-1-60761-987-1_18","volume":"696","author":"M Kohl","year":"2011","unstructured":"Kohl, M., Wiese, S. & Warscheid, B. Cytoscape: Software for visualization and analysis of biological networks. Methods Mol. Biol. 696, 291\u2013303 (2011).","journal-title":"Methods Mol. Biol."},{"key":"50964_CR120","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M. et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785\u20132791 (2009).","journal-title":"J. Comput. Chem."},{"key":"50964_CR121","first-page":"840","volume":"14","author":"GA Cardama","year":"2014","unstructured":"Cardama, G. A. et al. Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines. Citeseer 14, 840\u2013851 (2014).","journal-title":"Citeseer"},{"key":"50964_CR122","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3389\/fcell.2020.00240","volume":"8","author":"N Gonz\u00e1lez","year":"2020","unstructured":"Gonz\u00e1lez, N. et al. Computational and in vitro pharmacodynamics characterization of 1A\u2013116 Rac1 inhibitor: Relevance of Trp56 in its biological activity. Front. Cell Dev. Biol. 8, 240 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"50964_CR123","doi-asserted-by":"publisher","unstructured":"Ciarlantini, M. S. et al. Development of a New and Improved Guanidine-based Rac1 Inhibitor with in Vivo Activity against Non-Small Cell Lung Cancer. (2020) https:\/\/doi.org\/10.26434\/CHEMRXIV.12950309.V1.","DOI":"10.26434\/CHEMRXIV.12950309.V1"},{"key":"50964_CR124","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"50964_CR125","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: Biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"key":"50964_CR126","doi-asserted-by":"publisher","first-page":"e0184129","DOI":"10.1371\/journal.pone.0184129","volume":"12","author":"L Chen","year":"2017","unstructured":"Chen, L. et al. Prediction and analysis of essential genes using the enrichments of gene ontology and KEGG pathways. PLoS ONE 12, e0184129 (2017).","journal-title":"PLoS ONE"},{"key":"50964_CR127","doi-asserted-by":"publisher","first-page":"e0126492","DOI":"10.1371\/journal.pone.0126492","volume":"10","author":"L Chen","year":"2015","unstructured":"Chen, L. et al. Gene ontology and KEGG pathway enrichment analysis of a drug target-based classification system. PLoS ONE 10, e0126492 (2015).","journal-title":"PLoS ONE"},{"key":"50964_CR128","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."},{"key":"50964_CR129","doi-asserted-by":"publisher","first-page":"D109","DOI":"10.1093\/nar\/gkr988","volume":"40","author":"M Kanehisa","year":"2012","unstructured":"Kanehisa, M., Goto, S., Sato, Y., Furumichi, M. & Tanabe, M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 40, D109\u2013D114 (2012).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"50964_CR130","first-page":"22493","volume":"6","author":"O Manor","year":"2016","unstructured":"Manor, O. et al. Metagenomic evidence for taxonomic dysbiosis and functional imbalance in the gastrointestinal tracts of children with cystic fibrosis. Sci. Reports 6(1), 22493 (2016).","journal-title":"Sci. Reports"},{"key":"50964_CR131","doi-asserted-by":"publisher","first-page":"689531","DOI":"10.3389\/fphys.2021.689531","volume":"12","author":"J Hou","year":"2021","unstructured":"Hou, J. et al. LncRNAs participate in post-resuscitation myocardial dysfunction through the PI3K\/Akt signaling pathway in a rat model of cardiac arrest and cardiopulmonary resuscitation. Front. Physiol. 12, 689531 (2021).","journal-title":"Front. Physiol."},{"key":"50964_CR132","doi-asserted-by":"publisher","first-page":"e70381","DOI":"10.1111\/cns.70381","volume":"31","author":"C Wu","year":"2025","unstructured":"Wu, C. et al. Gut microbial tryptophan metabolism is involved in post-cardiac arrest brain injury via pyroptosis modulation. CNS Neurosci. Ther. 31, e70381 (2025).","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"50964_CR133","first-page":"16116","volume":"5","author":"S Mao","year":"2015","unstructured":"Mao, S., Zhang, M., Liu, J. & Zhu, W. Characterising the bacterial microbiota across the gastrointestinal tracts of dairy cattle: Membership and potential function. Sci. Reports 5(1), 16116 (2015).","journal-title":"Sci. Reports"},{"key":"50964_CR134","doi-asserted-by":"publisher","first-page":"100961","DOI":"10.1016\/j.resplu.2025.100961","volume":"25","author":"J Wang","year":"2025","unstructured":"Wang, J. et al. An untargeted metabolomics analysis suggests pathophysiological changes for post cardiac arrest syndrome. Resusc. Plus 25, 100961 (2025).","journal-title":"Resusc. Plus"},{"issue":"1","key":"50964_CR135","first-page":"12998","volume":"10","author":"Q Zeng","year":"2020","unstructured":"Zeng, Q. et al. The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients. Sci. Reports 10(1), 12998 (2020).","journal-title":"Sci. Reports"},{"issue":"1","key":"50964_CR136","first-page":"13560","volume":"11","author":"X Gu","year":"2021","unstructured":"Gu, X., Jin, B., Qi, Z. & Yin, X. Identification of potential microRNAs and KEGG pathways in denervation muscle atrophy based on meta-analysis. Sci. Reports 11(1), 13560 (2021).","journal-title":"Sci. Reports"},{"issue":"7","key":"50964_CR137","first-page":"43353","volume":"71","author":"K Yang","year":"2017","unstructured":"Yang, K. et al. A comprehensive analysis of metabolomics and transcriptomics in cervical cancer. Sci. Reports 71(7), 43353 (2017).","journal-title":"Sci. Reports"},{"issue":"1","key":"50964_CR138","first-page":"7827","volume":"9","author":"L Li","year":"2019","unstructured":"Li, L. et al. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics. Sci. Reports 9(1), 7827 (2019).","journal-title":"Sci. Reports"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50964-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50964-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50964-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:02:46Z","timestamp":1784120566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50964-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":138,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["50964"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-50964-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"22232"}}